NEOGENOMICS INC Annual Income Tax Expense (Benefit) in USD from 2011 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Neogenomics Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2011 to 2023.
- Neogenomics Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$150K, a 94.9% increase year-over-year.
- Neogenomics Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$2.11M, a 80.9% increase year-over-year.
- Neogenomics Inc annual Income Tax Expense (Benefit) for 2023 was -$9.13M, a 39.5% increase from 2022.
- Neogenomics Inc annual Income Tax Expense (Benefit) for 2022 was -$15.1M, a 124% decline from 2021.
- Neogenomics Inc annual Income Tax Expense (Benefit) for 2021 was -$6.73M, a 63.1% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)